Alexion Pharmaceuticals gets U.S. antitrust nod for Enobia buy
Alexion Pharmaceuticals has received U.S. antitrust approval for its purchase of Enobia Pharma, according to a Federal Trade Commission release Thursday.Washington – Biopharmaceutical firm Alexion Pharmaceuticals has received U.S. antitrust approval...To view the full article, register now.
Already a subscriber? Click here to view full article